FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2911324 · Received January 11, 2013

Report

Report Number
2124215-2012-15987
Event Type
Malfunction
Date Received
January 11, 2013
Date of Event
November 20, 2012
Report Date
November 29, 2012
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE SYSTEM DETECTED AN INCREASED PACING IMPEDANCE MEASUREMENT GREATER THAN 2,000 OHMS ON A NON-BSC RIGHT VENTRICULAR (RV) LEAD. ALL OTHER LEAD MEASUREMENTS WERE STABLE AND WITHIN ACCEPTABLE LIMITS. THE PATIENT WAS BROUGHT INTO THE CLINIC FOR FURTHER EVALUATION. POCKET MANIPULATION AND ISOMETRIC EXERCISES WERE UNREMARKABLE. IT WAS REPORTED THAT THE PATIENT WITH THIS DEVICE SYSTEM REPORTED LESS THAN ONE PERCENT. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THIS CLINICAL OBSERVATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
19144 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 75 YR 6947| E102